Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study
- 29 January 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 173 (1), 50-58
- https://doi.org/10.1111/bjd.13683
Abstract
Background The histopathological features of drug rash with eosinophilia and systemic symptoms (DRESS) syndrome remain poorly characterized. Objectives To better characterize the histopathological features of DRESS syndrome, and define the phenotype of the effector cells in the skin and compare it with maculopapular rash (MPR). Methods We conducted a retrospective study on 50 skin biopsies from patients with DRESS syndrome (n = 36). Histopathological and immunophenotypical features were studied and compared with a series of MPRs (n = 20). Results Foci of interface dermatitis, involving cutaneous adnexae, were frequently seen in cases of DRESS. Eosinophils were seen in only 20% of cases and neutrophils in 42%. Eczematous (40%), interface dermatitis (74%), acute generalized exanthematic pustulosis‐like (20%) and erythema multiforme‐like (24%) patterns were observed. The association of two or three of these patterns in a single biopsy was significantly more frequent in cases of DRESS than in a series of nondrug‐induced dermatoses (P < 0·01), and appeared to be more marked in DRESS syndrome with severe cutaneous lesions (P = 0·01) than in less severe cases of DRESS and MPR. A higher proportion of CD8+ and granzyme B+ lymphocytes was observed in cases of DRESS with severe cutaneous eruptions (erythroderma and/or bullae). Atypical lymphocytes were found in 28% of biopsies, and expressed CD8 in most cases; a cutaneous T‐cell clone was rarely found (6%). Conclusions The histopathology of DRESS syndrome highlights various associated inflammatory patterns in a single biopsy. Cutaneous effector lymphocytes comprise a high proportion of polyclonal CD8+ granzyme B+ T lymphocytes.Keywords
This publication has 17 references indexed in Scilit:
- Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 casesBritish Journal of Dermatology, 2013
- Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell ResponseScience Translational Medicine, 2010
- Defective Regulatory T Cells In Patients with Severe Drug Eruptions: Timing of the Dysfunction Is Associated with the Pathological Phenotype and OutcomePublished by The American Association of Immunologists ,2009
- Drug-Induced Hypersensitivity SyndromeMedicine, 2009
- Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in TaiwanJournal of the European Academy of Dermatology and Venereology, 2008
- In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruptionBritish Journal of Dermatology, 2008
- Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndromeBritish Journal of Dermatology, 2007
- Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndromeBritish Journal of Dermatology, 2006
- Drug-induced Hypersensitivity Syndrome(DIHS): A Reaction Induced by a Complex Interplay among Herpesviruses and Antiviral and Antidrug Immune ResponsesAllergology International, 2006
- Infiltration of cytotoxic T cells in drug‐induced cutaneous eruptionsClinical and Experimental Allergy, 2000